↓ Skip to main content

Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer

Overview of attention for article published in Clinical Cancer Research, April 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
65 X users

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer
Published in
Clinical Cancer Research, April 2020
DOI 10.1158/1078-0432.ccr-19-0306
Pubmed ID
Authors

Seyed Pairawan, Kenneth R. Hess, Filip Janku, Nora S. Sanchez, Kenna R. Mills Shaw, Cathy Eng, Senthilkumar Damodaran, Milind Javle, Ahmed O. Kaseb, David S. Hong, Vivek Subbiah, Siqing Fu, David R. Fogelman, Victoria M. Raymond, Richard B. Lanman, Funda Meric-Bernstam

X Demographics

X Demographics

The data shown below were collected from the profiles of 65 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 74 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 15%
Student > Bachelor 8 11%
Other 7 9%
Student > Master 6 8%
Student > Ph. D. Student 5 7%
Other 11 15%
Unknown 26 35%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Biochemistry, Genetics and Molecular Biology 11 15%
Agricultural and Biological Sciences 9 12%
Immunology and Microbiology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 2 3%
Unknown 30 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2022.
All research outputs
#1,162,531
of 25,775,807 outputs
Outputs from Clinical Cancer Research
#774
of 13,310 outputs
Outputs of similar age
#31,934
of 404,674 outputs
Outputs of similar age from Clinical Cancer Research
#24
of 164 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,310 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,674 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.